| Name | N-[[3-(4-Acetylphenyl)-2-Oxo-1,3-Oxazolidin-5-Yl]Methyl]Acetamide |
|---|---|
| Synonyms | N-[[3-(4-Acetylphenyl)-2-Oxo-Oxazolidin-5-Yl]Methyl]Acetamide; N-[[3-(4-Acetylphenyl)-2-Oxo-5-Oxazolidinyl]Methyl]Acetamide; N-[[3-(4-Acetylphenyl)-2-Keto-Oxazolidin-5-Yl]Methyl]Acetamide |
| Molecular Structure | ![]() |
| Molecular Formula | C14H16N2O4 |
| Molecular Weight | 276.29 |
| CAS Registry Number | 104421-21-8 |
| SMILES | C1=CC(=CC=C1N2CC(CNC(C)=O)OC2=O)C(C)=O |
| InChI | 1S/C14H16N2O4/c1-9(17)11-3-5-12(6-4-11)16-8-13(20-14(16)19)7-15-10(2)18/h3-6,13H,7-8H2,1-2H3,(H,15,18) |
| InChIKey | POXUJOYUVLWPQN-UHFFFAOYSA-N |
| Density | 1.239g/cm3 (Cal.) |
|---|---|
| Boiling point | 525.199°C at 760 mmHg (Cal.) |
| Flash point | 271.431°C (Cal.) |
| (1) | Philip Prathipati, Ngai Ling Ma* and Thomas H. Keller. Global Bayesian Models for the Prioritization of Antitubercular Agents, J. Chem. Inf. Model., 2008, 48 (12), pp 2362–2370 |
|---|---|
| Market Analysis Reports |
| List of Reports Available for N-[[3-(4-Acetylphenyl)-2-Oxo-1,3-Oxazolidin-5-Yl]Methyl]Acetamide |